---
description: â€œåäºŒæœˆçš„æŸä¸€å¤©é˜³å…‰æ˜¾å¾—ç‰¹åˆ«åˆºçœ¼â€ æ¨å®—çº¬ã€ŠOne dayã€‹
---

# 2019-12

## ğŸ˜20191219

* [x] BCMAxCD3 new **plasmid transfection**

| Name | Info |
| :--- | :--- |
| Samples Name | VHH-scFV; AAG |
| Positive control | 4AL4 HC &LC in pTT5 |
| transfection number | 4 |
| transfection plate & volume | 12 well plate, 1mL |
| Plasmids & PEI & OptiMEM usage | 2ug, 4ug, 100uL |
| transfection cell & density | 293T , 6e5/mL |

* [x] **send 3'-TCRb plate for sequencing**  

| Name | Info |
| :--- | :--- |
| sequencing primers | M13-F, M13-R |
| colonies number | 10 |

* [x] **TCRa RT-PCR**

| ID | Template | 5'  primer | 3' Primer | Result |
| :--- | :--- | :--- | :--- | :--- |
| 1 | Jurkat 5'&3' RACE cDNA | Jurkat-a-F | ACR Out & ACR inner | negative |
| 2 | Jurkat 3' RACE cDNA | Jurkat-a-F, TCRa-F | UPM | negative |
| 3 | Jurkat 3' RACE cDNA | Jurkat-b-F, TCRb-F | UPM | negative |

* [x] **HcAb total RNA RT &  PCR**

1. RT

| ID | Template | 5'  TS oligo  | 3' RT Primer |  |
| :--- | :--- | :--- | :--- | :--- |
| 1 | HcAb total RNA | SMART | Oligo-dT |  |
| 2 | HcAb total RNA | SMARTNNN | Oligo-dT |  |
| 3 | HcAb total RNA | SMART | mIgG1-HindgeR |  |

2. PCR

| ID | Template | 5'  primer | 3' Primer | Result |
| :--- | :--- | :--- | :--- | :--- |
| 1 | HcAb 5' RACE cDNA | UPM | Hindge-R | no band |
| 2 | HcAb 5' RACE cDNA | V-primer | Hindge-R | okay |
| 3 | HcAb 5' RACE cDNA | V-primer | J-primer | okay |

* [x] **Duo-V2 construction, 5' CMV-hcK & 3' CMV-hck é‡æ–°åˆ¶å¤‡**

| ID | Template, type | 5'  primer | 3' Primer | Size | Result |
| :--- | :--- | :--- | :--- | :--- | :--- |
| a | pTT5-mIgKL-hCK, plasmid | pTT5-S1-F | TAR2 | 2Kb | weak |
| b | K0 | pTT5-S1-F | TAR2 | 2Kb | weak |
| c | pTT5-mIgKL-hCK, plasmid | TAR-Barcode-mIGKL | S12-pTT5-R | 2.7Kb | weak |
| d |  CMV 5' +mIgKL-hcg1\(barcode\), PCR products | S12-CMV-F | S1-CMV-hcg1-R | 2.4kb | multiple bands |

## ğŸ˜Š20191220

* [ ] pTT5-TAR construction



* [ ] Duo-V2 construction

| ID | Template, type | 5'  primer | 3' Primer | Size | Result |
| :--- | :--- | :--- | :--- | :--- | :--- |
| a | pTT5-mIgKL-hCK, plasmid | pTT5-S1-F | TAR2 | 2Kb | okay |
| c | pTT5-mIgKL-hCK, plasmid | TAR-Barcode-mIGKL | S12-pTT5-R | 2.7Kb | no band  |
| d |  d from yesterday | S12-CMV-F | S1-CMV-hcg1-R | 2.4kb | okay  |
| e | MS011\(R1031\) | S12-EF1a-F | TAR9 | 1.3kb | very weak |
| f | MS011\(R1031\) | S12-EF1a-F | Duo-S1-R\(new\) | 3Kb | weak |

* [ ] * [x] R1031 Cell binding FACS
* [x] pTT5-TrastuzuMab add TAR element



## ğŸ˜‰20191221

* Introduced animals into the world, we believe they're going to be a neat addition.
* [ ] sorting 293F for æŸ¥æ´‹ï¼Œç»ƒæ‰‹AriaIII.

## ğŸ¤·â€â™‚ï¸20191222

* [x] Jurkat TCRb Sequence analysis

## ğŸ˜‹20191223

* [x] BCMAxCD3 IgG conc ELISA, hBCMA binding ELISA & CD3e peptide binding ELISA



* [x] DuoV2-EF1aCMV & CMV-CMV Colony PCR

> Results:

* [x] pTT5-TAR-Trastuzumab HC&LC colony PCR



* [x] HcAb HindgeNNN RT and PCR



## ğŸ¤¨20191224

* [ ] HSA HcAb NGS cDNA amplification

{% hint style="info" %}
1ug totalRNAå¯¹äº30ulçš„é€†è½¬å½•ååº”è¾ƒå¤šï¼Œå°¤å…¶æ˜¯å¦‚æœæŠŠå…¨éƒ¨é€†è½¬å½•çš„cDNAéƒ½å½“ä½œæ‰©å¢æ¨¡æ¿ï¼Œåˆ™ä¸èƒ½è·å¾—è¾ƒå¥½çš„PCRç»“æœã€‚éœ€è¦ç¨€é‡Š10å€å·¦å³ï¼Œå¦‚å–1ulç”¨äº50ulPCRååº”ã€‚

è€Œä»Šåï¼Œä¸€èˆ¬é€‰ç”¨500ngä½œä¸ºå•ä¸ªé€†è½¬å½•ååº”çš„ä¸Šé™ã€‚
{% endhint %}

{% hint style="warning" %}
Primestarå¯¹äºæ¨¡æ¿è¦æ±‚å¾ˆä¸¥æ ¼ï¼Œä»Šå¤©çš„5ä¸ªé€†è½¬å½•PCRååº”ï¼Œ2ä¸ªtotal-RNAä½¿ç”¨è¾ƒå¤š\(1ug,850ng\)çš„éƒ½æ²¡èƒ½æ‰©å¢å‡ºæ¥ï¼›è€Œ3ä¸ªtotal-RNAç›¸å¯¹è¾ƒå°‘\(500ng,200ng,200ng\)çš„æ ·å“åˆ™å¾—åˆ°äº†æ‰©å¢ã€‚

è€Œä¸”æ­¤å‰é‡å¤è¿‡å‡ æ¬¡ï¼ŒPrimeStaræ— æ³•ç”¨äºèŒè½PCRã€‚
{% endhint %}

* [ ] work update
* [ ] MS13 change vector

> Primer pair for vHï¼š
>
> Primer pair for vKï¼š

* [x] FACS data analysis
* [x] 293F ç»†èƒä¼ ä»£
* [x] BCMAxCD3 è½¬æŸ“: 50mL 293F, 100ug plasmid+ 200ug PEI 25KD
* [ ]  mRNA immunization plan
* [ ] TCRa sequencing

## ğŸ˜¶20191225



* [x] MS13 change vector

> a. transfer MS13 vH&vK from DuoV1 into pTT5-hcg1&hcK,  pTT5-TAR-hcg1&hcK

* [x] HSA \#1&\#2 RT-PCR

{% hint style="info" %}
1. RT-PCRä¹‹å‰å¿…é¡»å»é™¤æºå¸¦UMIçš„å¼•ç‰©ï¼Œæ‰€ä»¥å¿…é¡»è¿›è¡ŒcDNAçº¯åŒ–ï¼›
2. çº¯åŒ–å¯èƒ½é€ æˆæŸç§æŸå¤±ï¼ŒåŒæ—¶å¾ªç¯æ•°ä¸å®œè¿‡é«˜ï¼Œå¯¼è‡´NGSå»ºåº“ä¸Šæœºæ—¶ä¸¢å¤±å¤šæ ·æ€§ï¼Œå› æ­¤PCRååº”ä½“ç§¯ç›¸å¯¹è¾ƒå¤§ï¼Œ25ä¸ªå¾ªç¯ä¸ä¸€å®šèƒ½æ‹¿åˆ°è¶³å¤Ÿçš„cDNA
{% endhint %}

* [ ] Plasmid midi-prep and Transfection

> Trastuzumab with different condition and TAR -/+ plasmid

 



## ğŸ˜‘20191226

* [ ] åˆæˆEF1a-CMVå’ŒCMV-CMVçš„èŒè½PCRå¼•ç‰©ï¼Œæˆ–è€…è¾ƒç»™æ“ç§‘å»åšã€‚
* [x] MS13å››å—å¹³æ¿çš„èŒè½PCR
* [x] å¯„é€NGSæ ·å“



